Skip to main content
OpenTrials

Clinical trial condition

Cholangitis

Explore clinical trials studying Cholangitis. Study availability and eligibility vary by location and protocol.

104 public trials 28 recruiting studies
Refine in advanced search Browse all conditions

Cholangitis trial results

Active, not recruiting

Effect of Simvastatin on the Prognosis of Primary Primary Sclerosing Cholangitis (PSC)

NCT04133792

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholangitis, +3 more
Locations
  • Skåne Universitetssjukhus Malmö, Skåne County, Sweden
  • Norrlands Universitetssjukhus Umeå, Västerbotten County, Sweden
  • Sahlgrenska Universitetssjukhuset Gothenburg, Västra Götaland County, Sweden
  • Sahlgrenska Universitetssjukhuset Östra Gothenburg, Sweden
View Trial Details
Active, not recruiting

norUrsodeoxycholic Acid vs Placebo in PSC

NCT03872921

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholangitis, +3 more
Locations
  • Medical University of Vienna, Department of Internal Medicine III Vienna, Austria
  • Medical School Hannover Hanover, Lower Saxonia, Germany
View Trial Details
Completed

A POC and Dose-Ranging Study of HTD1801 in PSC Patients

NCT03333928

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholangitis, +3 more
Locations
  • Arizona Liver Health Chandler, Arizona, United States
  • Arizona Liver Health Tuscon, Arizona, United States
  • Fresno Clinical Research Center Fresno, California, United States
  • Keck School of Medicine of USC Los Angeles, California, United States
View all 26 locations
View Trial Details
Completed

CM-101 in PSC Patients -The SPRING Study

NCT04595825

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholangitis, +3 more
Locations
  • Scripps Clinic Torrey Pines - site P83 La Jolla, California, United States
  • UC Davis Health System - Midtown Ambulatory Care Center - site P79 Sacramento, California, United States
  • Northwestern University - site P77 Chicago, Illinois, United States
  • Massachusetts General Hospital - site P95 Boston, Massachusetts, United States
View all 33 locations
View Trial Details
Completed

Phase 2a Evaluation of Safety, Tolerability, and Pharmacokinetics of PLN-74809 in Patients With Primary Sclerosing Cholangitis (PSC)

NCT04480840

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholangitis, +3 more
Locations
  • California Liver Research Institute Pasadena, California, United States
  • Stanford University School of Medicine Redwood City, California, United States
  • University of California, Davis Medical Center Sacramento, California, United States
  • California Pacific Medical Center Research Institute San Francisco, California, United States
View all 60 locations
View Trial Details

Related conditions